Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.62 |
| ▸ | CA1 | P00915 | 2/20 | 0.62 |
| ▸ | CA2 | P00918 | 2/20 | 0.62 |
| ▸ | CA7 | P43166 | 2/20 | 0.62 |
| ▸ | CA9 | Q16790 | 2/20 | 0.62 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.62 |
| ▸ | CYP1A1 | P04798 | 8/20 | 0.54 |
| ▸ | CYP1B1 | Q16678 | 8/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 7/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.54 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.53 |
| ▸ | CYP2C8 | P10632 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | CYP4B1 | P13584 | 1/20 | 0.53 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.53 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.53 |
| ▸ | CYP2A7 | P20853 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14127541 | 1.00 | CA12 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29558143 | 1.00 | CA12 (0.62) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7403167 | 0.98 | CA12 (0.60) | CA12CA1CA2CA7CA9 | |
| SCHEMBL9383598 | 0.94 | CA12 (0.61) | CA12CA1CA2CA7CA9 | |
| SCHEMBL7819014 | 0.85 | CA12 (0.45) | CA12CA1CA2CA7CA9 | |
| SCHEMBL29634588 | 0.83 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL258418 | 0.83 | CA12 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL6449465 | 0.83 | CA1 (0.48) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12003966 | 0.83 | CA12 (0.43) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30250475 | 0.82 | CA1 (0.53) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 663 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113651832-B | Method for synthesizing optically pure glabridin | 河北工业大学 | 2022-08-16 | — | — | CN | claimed |
| CN-113637022-B | Method for synthesizing glabridin | 河北工业大学 | 2022-07-19 | — | — | CN | claimed |
| CN-111362961-B | Method for asymmetrically synthesizing optical purity glabridin | 玉林师范学院 | 2021-12-10 | — | — | CN | claimed |
| CN-113651832-A | Method for synthesizing optically pure glabridin | 河北工业大学 | 2021-11-16 | — | — | CN | claimed |
| CN-113637022-A | Method for synthesizing glabridin | 河北工业大学 | 2021-11-12 | — | — | CN | claimed |
| CN-111825715-A | Synthesis method of triphenylphosphine derivative tri- (R-phenyl) phosphine | 江苏富比亚化学品有限公司 | 2020-10-27 | — | — | CN | claimed |
| CN-111362961-A | Method for asymmetrically synthesizing optical purity glabridin | 玉林师范学院 | 2020-07-03 | — | — | CN | claimed |
| CN-109879732-A | A kind of preparation method of 1- (5- isopropyl -2,4- Dimethoxyphenyl) ethyl ketone | 上海卡洛化学有限公司 | 2019-06-14 | — | — | CN | claimed |
| US-20260102762-A1 | TRI-(ADAMANTYL)PHOSPHINES AND APPLICATIONS THEREOF | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260062393-A1 | Compounds | CTXT PTY LTD (AU) | 2026-03-05 | — | — | US | disclosed |
| US-12539508-B2 | Tri-(adamantyl) phosphines and applications thereof | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2026-02-03 | — | — | US | disclosed |
| EP-4680226-A2 | ACYLSULFONAMIDE KAT6A INHIBITORS | Olema Pharmaceuticals, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| US-20260015327-A1 | ACYLSULFONAMIDE KAT6A INHIBITORS | OLEMA PHARMACEUTICALS INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12509479-B2 | P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof | BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) | 2025-12-30 | — | — | US | disclosed |
| US-4487934-A | Method of preparing poly-substituted acylbenzenes | HOECHST-ROUSSEL PHARMACEUTICALS INC. (US) | 1984-12-11 | — | — | US | disclosed |
| US-4457875-A | ANTIDEPRESSANTS, TRANQUILIZERS | CHOAY S.A. (FR) | 1984-07-03 | — | — | US | disclosed |
| EP-0041682-B1 | A METHOD OF PREPARING POLY-SUBSTITUTED ACYLBENZENES | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1983-09-21 | — | — | EP | disclosed |
| EP-0045478-A1 | A method of preparing poly-substituted acylbenzenes | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1982-02-10 | — | — | EP | disclosed |
| EP-0041682-A1 | A method of preparing poly-substituted acylbenzenes | HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) | 1981-12-16 | — | — | EP | disclosed |
| US-4304941-A | Method of preparing poly-substituted acylbenzenes | HOECHST ROUSSEL PHARMACEUTICALS, INC. (US) | 1981-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12539508-B2 | Tri-(adamantyl) phosphines and applications thereof | OTC, AOC3, ICOSLG | CA12 179/4885CA1 225/4885CA2 235/4885 |
| US-20260062393-A1 | Compounds | SCN2B, ABCB11, SCN1B | CA12 906/4885CA1 1778/4885CA2 199/4885 |
| US-20260102762-A1 | TRI-(ADAMANTYL)PHOSPHINES AND APPLICATIONS THEREOF | PTMS, TEC, CD2 | CA12 1142/4885CA1 598/4885CA2 987/4885 |
| US-12509479-B2 | P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof | P2RX3, P2RX6, P2RX2 | CA12 3354/4885CA1 2186/4885CA2 683/4885 |
| US-20260015327-A1 | ACYLSULFONAMIDE KAT6A INHIBITORS | KAT6A, KAT2A, KAT6B | CA12 4276/4885CA1 2723/4885CA2 3408/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.